Furthermore, in a murine model of HCC on a background of fibrosis, the pharmacological inhibition of TAM recruitment via CCL2 showed a significant reduction in the extent of angiogenesis within tumours and, consequently, tumour progression, as measured by tumour volume [153]. The gene discussed is CCL2; the disease is hepatocellular carcinoma.